Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Refractory/Relapse Neuroblastoma 1 Papillomavirus Infections 1 Osteoporosis 1 Neuroendocrine Tumors 1 Neoplasms, Squamous Cell 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, B-Cell 1 Kidney Neoplasms 1 Inflammatory Bowel Diseases 1 Infertility 1 Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1 Hodgkin Disease 1 High Grade Cervical Intraepithelial Neoplasia 1 Esophageal Neoplasms 1 Burkitt Lymphoma 1

Interventions

pembrolizumab 300 Nivolumab 273 Ipilimumab 250 aldesleukin 137 Cyclophosphamide 136 Interleukin-2 105 trametinib 82 dabrafenib 76 Temozolomide 75 Dacarbazine 74 Vemurafenib 71 fludarabine 68 fludarabine phosphate 62 Biopsy 49 binimetinib 47 sargramostim 44 Radiosurgery 44 Bevacizumab 43 Paclitaxel 42 encorafenib 40 incomplete Freund's adjuvant 39 atezolizumab 38 Radiotherapy 37 Cisplatin 36 CTLA-4 Antigen 36 Specimen Handling 35 Magnetic Resonance Spectroscopy 35 Carboplatin 35 cobimetinib 34 Introns 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Biological Products × Clear all

NCT02828202 2025-02-11

MelBase

Assistance Publique - Hôpitaux de Paris

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡